Own Goal
Practical M&A advice - making an acquisition

Bourn Bioscience Buyout

Another completed transaction.  PEM Corporate Finance were lead adviser to the Management Buyout of Bourn Hall from Serono.   Bourn Bioscience as it is now called trades as ‘Bourn Hall Clinic’, the world’s first in-vitro fertilisation clinic, and as ‘LCG Bioscience’, offering clinical research and development services to the biotechnology and pharmaceutical industry.

Management_buyout_team_sm  Apart from the high profile of the business the deal was noteworthy for the speed with which we had to put it together.  Only around six weeks elapsed from signing heads to completion, with completion just before christmas.  Much more detail on our website.  Thanks to many but especially Tom Pickthorn and his cast of thousands at Mills & Reeve,  and to Nick Baker at Barclays.

Photo Caption (left to right): Mike Macnamee - Chief Executive Director, Bourn Hall Ltd. Tom Pickthorn - Partner in Finance Corporate Team, Mills & Reeve. Nicola Graver - Human Resources Director, Bourn Hall Ltd. Neil Burton - Senior Solicitor, Mills & Reeve. Lake Falconer - Partner at PEM Corporate Finance LLP. Dawn Wilkerson - IT and Core Services Director, Bourn Hall Ltd. Lisa Gibbons - Clinical Research Director, Bourn Hall Ltd and Simon Barton - Finance Director, Bourn Hall Ltd.

Comments

The comments to this entry are closed.